Inogen, Inc.

Inogen, Inc.

INGN·NASDAQ

$6.09

+6.1%
HealthcareMedical - Devices

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

At a Glance

Live Snapshot
Market Cap$164.88M
EPS-0.8500
P/E Ratio-8.03
Earnings Date08/06/2026

ingn

Total Debt

Last Annual Value

17.48M

3-Year CAGR

-9%

5-Year CAGR

12%

10-Year CAGR

49%

Inogen, Inc.

Inogen, Inc. Competitors Analysis of Total Debt

INGN · NASDAQ
CompanyTotal Debt
CAGR 3Y
CAGR 5Y
CAGR 10Y
INGN logo
Inogen, Inc.
NASDAQ:INGN
17.48M
-7.3%-8.1%N/A 
1.63M
-13.9%20.1%N/A
CVRX logo
CVRx, Inc.
NASDAQ:CVRX
50.79M
18.4%N/AN/A
13.20M
-0.8%1.5%N/A
1.00M
3.4%4.4%-24.4%
198.00K
7.1%17.9%-16.5%
15.02M
1.3%N/AN/A
37.24M
-3.5%11.2%13.8%
171.24M
-11.7%-3.5%N/A
104.52M
-8.4%22.6%N/A
22.97M
-9.0%-4.1%15.3%
Inogen, Inc.

Inogen, Inc. Fair Value Envelope

INGN · NASDAQ

Our analysis suggests that INGN has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $6.09, this represents a potential HIDDEN relative to our calculated worth for Inogen, Inc..

Intrinsic Value
Current Price: $6.09